Detalhe da pesquisa
1.
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein.
Cell
; 184(9): 2316-2331.e15, 2021 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33773105
2.
The Intestinal Microbiome Restricts Alphavirus Infection and Dissemination through a Bile Acid-Type I IFN Signaling Axis.
Cell
; 182(4): 901-918.e18, 2020 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32668198
3.
A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies.
Cell
; 182(3): 744-753.e4, 2020 08 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32553273
4.
A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2.
Cell
; 183(1): 169-184.e13, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32931734
5.
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains.
Nature
; 596(7870): 103-108, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34153975
6.
Potently neutralizing and protective human antibodies against SARS-CoV-2.
Nature
; 584(7821): 443-449, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32668443
7.
CD4+ and CD8+ T cells are required to prevent SARS-CoV-2 persistence in the nasal compartment.
bioRxiv
; 2024 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38410446
8.
A broadly reactive antibody targeting the N-terminal domain of SARS-CoV-2 spike confers Fc-mediated protection.
Cell Rep Med
; 4(12): 101305, 2023 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38039973
9.
Thioredoxin-mediated alteration of protein content and cytotoxicity of Acinetobacter baumannii outer membrane vesicles.
Exp Biol Med (Maywood)
; 247(3): 282-288, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34713732
10.
Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains.
Sci Transl Med
; 14(630): eabm3302, 2022 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34846168
11.
Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease.
Cell Host Microbe
; 29(7): 1151-1161.e5, 2021 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34192518
12.
Ultrapotent miniproteins targeting the receptor-binding domain protect against SARS-CoV-2 infection and disease in mice.
bioRxiv
; 2021 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33688650
13.
Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains.
bioRxiv
; 2021 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34462745
14.
An intranasal vaccine durably protects against SARS-CoV-2 variants in mice.
Cell Rep
; 36(4): 109452, 2021 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34289385
15.
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein.
bioRxiv
; 2021 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33501445
16.
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains.
Res Sq
; 2021 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34013259
17.
Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice.
Cell Host Microbe
; 28(3): 465-474.e4, 2020 09 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32798445
18.
Replication-competent vesicular stomatitis virus vaccine vector protects against SARS-CoV-2-mediated pathogenesis.
bioRxiv
; 2020 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32676597
19.
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein.
bioRxiv
; 2020 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32511414
20.
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein.
Nat Med
; 26(9): 1422-1427, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32651581